Seroquel
Product Images NDC 64725-0282

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Seroquel (NDC 64725-0282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0280)

Label for SEROQUEL XR 50 mg tablet in a 30-count bottle, originally manufactured by AstraZeneca and repackaged by TYA Pharmaceuticals. The label includes prescription-only status, placeholder lot and expiration dates, repackager address in Tallahassee, FL, and a barcode.*

FDA Label Image

Label Image (64725 0281)

Packaging label for SEROQUEL XR 150 mg tablet, quantity 60 count. The manufacturer is AstraZeneca, and the product is repackaged by T.Y.A. Pharmaceuticals, located in Tallahassee, FL. The label includes placeholder lot and expiration information, a barcode, and a note to see the package insert for dosing information.*

FDA Label Image

Label Image (64725 0282)

SEROQUEL XR 200MG tablet label indicating a 60 count bottle (60CTBTL). The label notes prescription use only and displays manufacturer AstraZeneca. It is repackaged by TYA Pharmaceuticals, Tallahassee, FL, with contact phone number (850) 385-0228. Lot number, expiration date, and dose instructions are present but not fully detailed.*

FDA Label Image

Label Image (64725 0283)

SEROQUEL XR 300 mg tablet label indicating a bottle of 60 tablets. Manufactured by AstraZeneca and repackaged by TYA Pharmaceuticals, located at 2030 Crescent Dr., Tallahassee, FL 32301. The label includes an NDC number, a barcode, and dosing instructions to see package insert.*

FDA Label Image

Label Image (64725 0284)

Packaging label for SEROQUEL XR 400 MG TABLET in a bottle of 60 tablets. The label includes prescription-only status, a lot number placeholder, expiration date placeholder, manufacturer AstraZeneca, and repackager T.Y.A Pharmaceuticals with contact information in Tallahassee, FL. Directions to see the package insert for dosing are also noted.*

FDA Label Image

Structural Formula (89481c58 8da5 4636 9f86 562768009d8f 01)

Chemical structure of the active ingredient in SEROQUEL XR, showing the molecular arrangement of the compound as submitted by TYA Pharmaceuticals.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (89481c58 8da5 4636 9f86 562768009d8f 02)

A line graph showing the proportion of patients with relapse (%) over time in months. The graph compares two groups: PLA (placebo) represented by a dashed line, and QTP XR (SEROQUEL XR) represented by a solid line, illustrating differences in relapse rates over a 7-month period.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (89481c58 8da5 4636 9f86 562768009d8f 03)

A survival curve chart showing the proportion of patients with relapse (%) over time in weeks, with two lines representing QTP+ LI/VAL and PLA+ LI/VAL treatment groups. The y-axis ranges from 0 to 100% relapse, and the x-axis from 0 to 100 weeks. The chart compares relapse rates between the two groups over the study period.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (89481c58 8da5 4636 9f86 562768009d8f 04)

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two groups are compared: QTP+ Li/Val and PLA+ Li/Val, with relapse rates increasing over approximately 100 weeks. The QTP+ Li/Val group has a lower relapse proportion compared to the PLA+ Li/Val group throughout the timeline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.